. A similar study reported that Mn-SOD overexpression in the RVLM inhibits the ANG II pressor response following RVLM administration. RVLM levels of Mn-SOD mRNA, protein, and activity are drastically reduced in spontaneously hypertensive rats (SHR) compared with normotensive Wistar-Kyoto (WKY) rats. Furthermore, overexpression of Mn-SOD in the RVLM of SHR significantly attenuates mean arterial pressure (4). In addition, decreased Mn-SOD levels in the RVLM are observed in rabbits with chronic heart failure (12). Together, these data indicate that mitochondria-produced O 2 ·Ϫ is involved in the pathogenesis of cardiovascular diseases, including hypertension and heart failure, associated with increased sympathetic activation and brain angiotensinergic signaling. However, a direct link between ANG II and increased levels of mitochondrial O 2 ·Ϫ in neurons, as well as the mechanism(s) by which mitochondria-produced O 2 ·Ϫ modulates ANG II-dependent intraneuronal signaling and neuronal activation, has yet to be elucidated.
·Ϫ
-scavenging enzyme Mn-SOD. To examine the biological significance of the ANG II-mediated increase in mitochondria-produced O 2 ·Ϫ , we used the whole cell configuration of the patch-clamp technique to record the well-characterized ANG IIinduced inhibition of voltage-gated K ϩ current (IKv) in neurons. Adenovirus-mediated Mn-SOD overexpression or pretreatment with the cellpermeable antioxidant tempol (1 mM) significantly attenuated ANG II-induced inhibition of I Kv. In contrast, pretreatment with extracellular SOD protein (400 U/ml) had no effect. Mn-SOD overexpression also inhibited ANG II-induced activation of Ca 2ϩ /calmodulin kinase II, a redox-sensitive protein known to modulate I Kv. These data indicate that ANG II increases mitochondrial O 2 ·Ϫ , which mediates, at least in part, ANG II-induced activation of Ca 2ϩ /calmodulin kinase II and inhibition of I Kv in neurons. manganese superoxide dismutase; SOD2; calcium/calmodulin kinase II; CATH.a neurons; MitoSOX Red THE PATHOGENESIS OF VARIOUS cardiovascular diseases, including hypertension and heart failure, involves increased ANG II-dependent signaling in the central nervous system (CNS) (32, 41) . Elevated levels of ANG II in the CNS enhance neuronal activation by modulating ion currents, particularly voltage-gated Ca 2ϩ and K ϩ current (I Kv ), across neuronal cell membranes (27) . Increased excitatory neuronal firing in autonomic control regions of the brain, including the subfornical organ (SFO) (9) , paraventricular nucleus (1) , and rostral ventrolateral medulla (RVLM) (11) , ultimately drives the deleterious sympathoexcitation commonly associated with cardiovascular disorders. Recently, numerous studies have identified NADPH oxidase-derived reactive oxygen species (ROS), particularly superoxide (O 2 ·Ϫ ), as key intermediates in brain angiotensinergic signaling (15, 36) . In contrast, few studies have focused on mitochondria as a source of O 2 ·Ϫ in ANG II-stimulated neurons.
The involvement of mitochondria-produced O 2 ·Ϫ in modulating central ANG II-induced cardiovascular responses was first reported in a study showing that overexpression of Mn-SOD, the mitochondria-targeted isoform of the O 2 ·Ϫ -scavenging enzyme, in the SFO of mice markedly attenuates acute, central ANG IIinduced cardiovascular responses (38) . A similar study reported that Mn-SOD overexpression in the RVLM inhibits the ANG II pressor response following RVLM administration. RVLM levels of Mn-SOD mRNA, protein, and activity are drastically reduced in spontaneously hypertensive rats (SHR) compared with normotensive Wistar-Kyoto (WKY) rats. Furthermore, overexpression of Mn-SOD in the RVLM of SHR significantly attenuates mean arterial pressure (4) . In addition, decreased Mn-SOD levels in the RVLM are observed in rabbits with chronic heart failure (12) . Together, these data indicate that mitochondria-produced O 2 ·Ϫ is involved in the pathogenesis of cardiovascular diseases, including hypertension and heart failure, associated with increased sympathetic activation and brain angiotensinergic signaling. However, a direct link between ANG II and increased levels of mitochondrial O 2 ·Ϫ in neurons, as well as the mechanism(s) by which mitochondria-produced O 2 ·Ϫ modulates ANG II-dependent intraneuronal signaling and neuronal activation, has yet to be elucidated.
ANG II increases neuronal activity or firing rate by modulating the frequency of action potentials, which ultimately depends on the activity of membrane ion channels. Previous studies by Raizada, Sumners, and colleagues clearly identified ANG II-induced inhibition of I Kv , particularly the delayed rectifier K ϩ current, as a key mechanism by which ANG II evokes changes in neuronal activity (28 -30, 35) . Using primary neurons isolated from rat hypothalamus and brain stem or a catecholaminergic neuronal cell line (CATH.a neurons), they demonstrated that an ANG II-mediated increase in neuronal activity involves the activation of PKC and Ca 2ϩ /calmodulin kinase II (CaMKII) (28, 30) . Additionally, they previously demonstrated that the ANG II-induced inhibition of I Kv and the increase in neuronal firing rate are mediated, at least in part, by NADPH oxidase-derived ROS (29) .
Considering 
MATERIALS AND METHODS
CATH.a neuronal cell culture. Catecholaminergic CATH.a neuronal cells (stock no. CRL-11179, American Type Culture Collection, Manassas, VA) were cultured in RPMI 1640 medium supplemented with 8% normal horse serum, 4% fetal bovine serum, and 1% penicillin-streptomycin, as recommended by the supplier of the cell line. Before experimentation, CATH.a neurons were differentiated for 6 -8 days by addition of N 6 ,2=-O-dibutyryladenosine 3=,5=-cyclic monophosphate sodium salt (1 mM) to the culture medium, as previously described (7) . CATH.a neurons are commonly used to examine ANG II-dependent signaling mechanisms, as these cells express the ANG II type 1 (AT 1) and type 2 (AT2) receptors (28) .
Adenoviral vectors. Replication-deficient recombinant adenovirus encoding human Mn-SOD (AdMnSOD), constructed as previously described (39) , was obtained from Viraquest (North Liberty, IA). Control adenovirus containing only the cytomegalovirus promoter (AdEmpty) was also provided by Viraquest. Adenoviral titers were 1-2 ϫ 10 12 viral particles/ml and 3-5 ϫ 10 10 plaque-forming units/ ml. Pilot studies revealed that 50 multiplicity of infection of adenovirus was sufficient to induce gene expression without inducing neuronal toxicity (data not shown); thus, for studies reported here, CATH.a neurons were infected with 50 multiplicity of infection of adenovirus 4 days before experimentation.
Measurement of mitochondria-localized O 2 ·Ϫ . Levels of mitochondria-localized O2 ·Ϫ were measured using the mitochondria-targeted, O2
·Ϫ -sensitive fluorogenic probe MitoSOX Red (Invitrogen/Molecular Probes, Carlsbad, CA), as we previously described (39) . Briefly, noninfected control, AdEmpty-infected, or AdMnSOD-infected CATH.a neurons were loaded with MitoSOX Red (1 M) for 20 min, and baseline MitoSOX Red fluorescence was captured using a confocal laser scanning microscope (Zeiss 510 Meta). After 20 min of acute ANG II (100 nM) stimulation, MitoSOX Red fluorescence in the same cells was recaptured. Fluorescence intensity was quantified by establishing each neuron as a region of interest using Zeiss LSM 510 analysis software. Pre-ANG II (baseline) and post-ANG II MitoSOX Red fluorescence intensities were measured. Then the percent increase in fluorescence from baseline in each cell was determined by dividing the post-ANG II fluorescence intensity value by the baseline value of that particular cell. As previously characterized and described by Robinson and colleagues (24, 25) , we detected MitoSOX Red fluorescence using a 405-nm excitation wavelength, which selectively detects the O 2 ·Ϫ -specific 2-hydroxyethidium product of oxidized MitoSOX Red. To confirm mitochondrial localization of MitoSOX Red, neurons were also loaded with 50 nM MitoTracker Green (Invitrogen/Molecular Probes) for 30 min.
Isolation of mitochondria from CATH.a neurons. To confirm mitochondrial localization of Mn-SOD after adenovirus-mediated gene transfer, mitochondria were isolated as described previously with minor modifications (23). CATH.a neurons were resuspended in ice-cold buffer A (225 mM mannitol, 65 mM sucrose, 1 mM EGTA, and 10 mM HEPES, pH 7.2) and processed with a glass Dounce homogenizer. Homogenates were centrifuged at 500 g for 6 min at 4°C, and supernatants were collected and saved. Pellets were resuspended in buffer A, homogenized, and centrifuged again at 500 g for 6 min at 4°C. This process was repeated 3 times. Finally, all supernatants were pooled and centrifuged at 10,000 g for 10 min at 4°C to obtain mitochondria-enriched pellets. Mitochondria pellets were resuspended in ice-cold buffer B (225 mM mannitol, 65 mM sucrose, and 10 mM HEPES, pH 7.2), centrifuged, and washed five times. The final mitochondria-enriched pellet was resuspended in buffer B (ϳ30% vol/vol).
Mn-SOD activity assay. Mn-SOD activity in whole cell lysates and isolated mitochondria was measured using a semiquantitative native in-gel SOD activity assay, as previously described (2) . After separation of 60 g of whole cell lysate or mitochondria protein on a nondenaturing native gel using electrophoresis, the gel was stained with 2.4 mM nitro blue tetrazolium, 28 M riboflavin, and 28 mM N,N,N,N-tetramethylethylenediamine for 20 min in darkness. Mn-SOD activity was visualized by illumination of the gel under a fluorescent light until achromatic bands appeared.
Western blot analysis. Adenovirus-mediated overexpression of Mn-SOD in whole cell lysates and isolated mitochondria was confirmed using standard Western blot analysis. At 4 days after viral infection, 5 g of whole cell lysate or mitochondria protein were separated by SDS-PAGE and transferred to a nitrocellulose membrane. Membranes were incubated with anti-Mn-SOD polyclonal IgG (Upstate Biotech/Millipore, Billerica, MA), and bands were visualized using the Pierce enhanced chemiluminescence detection system (Thermo Scientific, Rockford, IL) after incubation with appropriate horseradish peroxidase-conjugated secondary antibodies. Purity of mitochondrial preparations was monitored using antibodies directed against lactate dehydrogenase (1:1,000 dilution; Abcam, Cambridge, MA), a cytosol marker, and cytochrome c oxidase subunit IV (1:1,000 dilution; Abcam), a mitochondria marker.
ANG II-induced activation of CaMKII was determined by Western blot analysis of phosphorylated CaMKII. For investigation of the time course of CaMKII activation, noninfected control neurons were incubated with ANG II (100 nM) for 0, 1, 2, or 5 min. In a separate set of experiments, CATH.a neurons infected with AdEmpty or AdMnSOD were stimulated with ANG II. Cells were harvested in lysis buffer containing protease and phosphatase inhibitors (Roche, Indianapolis, IN), and whole cell lysates were separated by SDS-PAGE. Membranes were incubated with anti-phosphorylated (Thr 286 ) CaMKII (Affinity BioReagents). Densitometric analysis of band intensity was determined using Image J analysis software. Actin was used to control for protein loading and to normalize signal intensities.
Immunofluorescence. At 4 days after viral infection, CATH.a neurons were incubated with the mitochondria marker MitoTracker Red (250 nM; Invitrogen/Molecular Probes) for 30 min in HBSS and then washed with 0.1 M phosphate buffer (PB) before initiation of immunofluorescence staining for Mn-SOD. Neurons were fixed with 4% paraformaldehyde for 20 min at room temperature and incubated with blocking solution (10% normal horse serum in 0.1 M PB) for 1 h at room temperature and then with antibody directed against human Mn-SOD (1:500 dilution; The Binding Site, Birmingham, UK) in 0.1 M PB containing 2% normal horse serum and 0.3% Triton X-100 at 4°C overnight. On the following day, neurons were washed and incubated with FITC-conjugated secondary antibody (1:200 dilution; The Binding Site) at room temperature for 2 h. After washout of secondary antibody, fluorescent images were captured using a confocal laser scanning microscope (Zeiss LSM 510 Meta).
Electrophysiology. K ϩ currents (IKv) were recorded from CATH.a neurons using a patch-clamp amplifier (model PC-505B, Warner Instrument, Hamden, CT) and the whole cell configuration of the patch-clamp technique. The patch pipette had resistances of 4 -6 M⍀ when filled with (in mM) 130 KCl, 2 MgCl2, 0.25 CaCl2, 5 EGTA, 1 Mg-ATP, 0.1 Tris-GTP, 10 HEPES, and 8 glucose, pH 7.2. The extracellular solution consisted of (in mM) 137 NaCl, 5.4 KCl, 1.35 CaCl2, 2 MgCl2, 0.3 NaH2PO4, 10 HEPES, and 10 sucrose, pH 7.4. Na ϩ and Ca 2ϩ channels were blocked by TTX (0.5 M) and CdCl2 (0.3 mM), respectively. Current traces were sampled at 10 kHz and filtered at 5 kHz. Holding potential was Ϫ80 mV. Current-voltage relations were elicited by test potentials of Ϫ80 to ϩ80 mV in 10-mV increments over 400-ms duration (5 s between steps). Following this protocol, we were able to measure peak K ϩ current (Ipeak), which includes a combination of the transient outward K ϩ current and the rising phase of the steady-state current (Iss) or delayed rectifier current. Since the contribution of transient outward K ϩ current is negligible at the end of a 400-ms pulse, current at that point (Iss) was measured to assess delayed rectifier current. Current density of Ipeak and Iss was calculated by dividing the respective current by membrane capacitance (Cm). Cm was determined by integrating the capacity current evoked by a voltage step of 5 mV and dividing the resulting charge by the voltage step. C m for the CATH.a neurons used in this study ranged from 15 to 35 pF and was not significantly different between experimental groups.
The data points of current density were plotted against the corresponding test potential. pClamp 8.1 (Axon Instruments) was used for data acquisition and analysis. Recordings were performed at 22°C. The effect of acute ANG II (100 nM) on current density was tested by superfusing neurons with the peptide for 5 min and repeating the voltage pulse regimen. ANG II inhibited I Kv in 87% of control CATH.a neurons tested in this study; therefore, to confirm that a given neuron was responsive to ANG II, each cell was treated with ANG II (100 nM), which was washed out before superfusion with experimental agents (see below). If ANG II did not inhibit I Kv, that cell was excluded from further analysis. To determine the contribution of AT1 vs. AT2 receptors, a subset of neurons were superfused with the AT1 receptor antagonist losartan (1 M) or the AT2 receptor antagonist PD-123319 (1 M) before and during ANG II superfusion. To investigate the involvement of extracellular vs. intracellular ROS, additional groups of neurons were superfused with extracellular SOD (ecSOD) protein (400 U/ml) or the cell-permeable antioxidant tempol (1 mM). Notably, for these experiments, the same neuron was subjected to the patch-clamp protocol after superfusion with vehicle, ecSOD, tempol, ecSOD ϩ ANG II, or tempol ϩ ANG II. Finally, subsets of neurons were infected with AdMnSOD or AdEmpty for specific examination of the role of mitochondria-produced O 2 ·Ϫ . Statistical analysis. Values are means Ϯ SE. Data were analyzed by Student's t-test for two-group comparisons or by ANOVA followed by Newman-Keuls correction for multiple comparisons. Differences were considered significant at P Ͻ 0.05.
RESULTS

ANG II increases mitochondria-localized O 2
·Ϫ levels in CATH.a neurons. Adenovirus-mediated overexpression of Mn-SOD in SFO (38) or RVLM (20) neurons attenuates the pressor response of ANG II administered into these cardiovascular control brain regions. Considering that Mn-SOD is efficiently targeted to mitochondria and is the SOD isoform that specifically scavenges mitochondria-localized O 2 ·Ϫ , we speculated that ANG II increases mitochondria-produced O 2 ·Ϫ in central neurons. Using CATH.a neurons, a central catecholaminergic neuronal cell line, and the mitochondria-targeted O 2 ·Ϫ -sensitive fluorogenic probe MitoSOX Red, we observed that acute ANG II stimulation significantly increases O 2 ·Ϫ levels in neuron mitochondria. As demonstrated in the representative confocal microcopy images and summary data ( Fig. 1; n Fig. 1A) . Additionally, the ANG II-induced increase in MitoSOX Red fluorescence was markedly attenuated in neurons infected with AdMnSOD ( Fig. 1B ; n ϭ 49 neurons on 5 coverslips, P Ͻ 0.05 vs. control neurons), whereas AdEmptytreated neurons (n ϭ 44 neurons on 4 coverslips) exhibited a significant increase in MitoSOX Red fluorescence similar to that of noninfected neurons following ANG II stimulation (Fig.  1B) . These data clearly show that ANG II increases mitochondria-produced O 2 ·Ϫ in neurons and that overexpression of Mn-SOD significantly reduces these elevated levels of O 2 ·Ϫ .
AdMnSOD infection increases Mn-SOD expression and activity in mitochondria.
To confirm adenovirus-mediated overexpression of active Mn-SOD in mitochondria, we measured Mn-SOD activity and protein levels in whole cell lysates and isolated mitochondria from control, AdEmpty-treated, and AdMnSODinfected CATH.a neurons. Mn-SOD activity ( Fig. 2A, top) and protein levels ( Fig. 2A, bottom) were markedly increased in whole cell lysates and mitochondria-enriched fractions 4 days after infection of CATH.a neurons with AdMnSOD compared with neurons infected with control virus AdEmpty and noninfected control cells. The enhanced endogenous (mouse) and adenovirusencoded (human) Mn-SOD activity in the mitochondrial fraction compared with whole cell lysates is consistent with obtaining enriched fractions of mitochondria. Additionally, the lack of lactate dehydrogenase (LDH, a cytosolic marker) expression and the increased expression of cytochrome c oxidase subunit IV (oxIV, a mitochondria marker) in mitochondria preparations compared with whole cell lysates further demonstrate that pure mitochondria were isolated.
To provide additional evidence that AdMnSOD infection increases Mn-SOD expression in mitochondria, we used confocal microscopy to examine the colocalization of Mn-SOD and MitoTracker Red, a fluorescent mitochondria marker, in control, AdEmpty-treated, and AdMnSOD-infected cells. Representative fluorescent images (Fig. 2B ) illustrate colocalization (yellow fluorescence in merged image) of Mn-SOD and MitoTracker Red in AdMnSOD-treated cells. We utilized an Mn-SOD primary antibody directed against human Mn-SOD to specifically detect adenovirus-encoded Mn-SOD expression; thus control and AdEmpty-infected CATH.a neurons did not exhibit Mn-SOD immunoreactivity (Fig. 2B) . In contrast, we utilized an Mn-SOD antibody that recognizes human and mouse Mn-SOD for the Western blot analysis (Fig. 2A) .
ANG II inhibits K ϩ current in CATH.a neurons via AT 1 receptor activation. To examine the biological significance of the ANG II-induced increase in neuron mitochondria O 2 ·Ϫ levels and to begin investigating the mechanism(s) by which Mn-SOD overexpression inhibits the central ANG II-induced pressor response (20, 38) , we sought to measure ANG IIdependent changes in the electrophysiological properties, particularly I Kv , of neurons overexpressing Mn-SOD. We initiated this series of experiments by first recording acute ANG IIinduced changes in I Kv in control CATH.a neurons. Compared with vehicle-treated CATH.a neurons, ANG II inhibited I Kv , which was restored after washout of ANG II (Fig. 3A) . In addition to inhibiting the delayed K ϩ current (I ss ) by 45 Ϯ 4% ( Fig. 3C ; P Ͻ 0.05 vs. vehicle), ANG II also significantly attenuated the transient current (I peak ) by 49 Ϯ 7% compared with neurons superfused with vehicle ( Fig. 3B ; P Ͻ 0.05 vs. vehicle, n ϭ 14 neurons). These results are similar to those reported previously by others (7, 28, 29, 35) . To determine the contribution of AT 1 vs. AT 2 receptors in mediating the ANG II-induced inhibition of I Kv , a subset of neurons were pretreated with losartan (n ϭ 6) or PD-123319 (n ϭ 8), respectively. Summary data presented in Fig. 3D show that losartan significantly attenuated ANG II-induced inhibition of I peak and I ss , whereas ANG II induced a similar inhibition of I Kv in PD-123319-treated neurons compared with vehicle-treated cells. Together, these results confirm previous data indicating that acute ANG II signaling results in inhibition of neuronal I Kv through an AT 1 receptor-dependent mechanism.
Intracellular (Fig. 4A, left) and the summary data showing the current density-voltage relationship for I ss (Fig. 4A, right; n ϭ 10 neurons) . However, ANG II did significantly reduce I ss in CATH.a neurons preincubated with ecSOD protein (n ϭ 10 neurons, P Ͻ 0.05 for vehicle vs. ecSOD ϩ ANG II; Fig. 4B ). The ANG II-induced inhibition of I peak (49 Ϯ 7%) was also significantly attenuated by tempol (13 Ϯ 4%), but not by ecSOD (33 Ϯ 7%). Superfusion of tempol or ecSOD alone did not significantly alter I Kv in CATH.a neurons (Fig. 4) . Together, these data indicate that intracellular, but not extracellular, O 2 ·Ϫ is involved in the ANG II intraneuronal signaling pathway leading to I Kv inhibition.
Mn-SOD overexpression attenuates ANG II-induced inhibition of I Kv .
Although tempol is commonly used as an SOD mimetic, as it can scavenge O 2 ·Ϫ , it can work as an antioxidant through an array of diverse mechanisms. For example, tempol can promote heme-mediated catalase-like activity, terminate radical chain reactions, and trap carbon-centered radicals (21) . Because of these nonspecific actions of tempol and to directly investigate the role of mitochondria-produced O 2 ·Ϫ , we utilized adenovirus-mediated gene transfer of Mn-SOD and examined ANG II-induced changes in I Kv . Overexpression of Mn-SOD virtually abolished ANG II-induced inhibition of I Kv (11 Ϯ 2% inhibition of I peak and 9 Ϯ 3% inhibition of I ss , n ϭ 7 neurons) compared with control neurons infected with AdEmpty (34 Ϯ 5% inhibition of I peak and 36 Ϯ 4% inhibition of I ss , P Ͻ 0.05 vs. AdMnSOD-infected neurons, n ϭ 8 neurons; Fig. 5 ). Taken together with data presented in Figs. 1-4 , these results indicate that, through an AT 1 receptor-dependent mechanism, ANG II-induced inhibition of I Kv in CATH.a neurons is mediated by an increase in mitochondrialocalized O 2 ·Ϫ levels.
Mn-SOD overexpression inhibits ANG II-induced activation of CaMKII.
To begin exploring a possible mechanism by which mitochondria-produced O 2 ·Ϫ mediates ANG II-induced inhibition of I Kv in neurons, we tested the hypothesis that Mn-SOD overexpression modulates ANG II-induced activation of CaMKII. CaMKII is a redox-sensitive protein (14) known to be involved in mediating ANG II-induced neuronal firing and inhibition of I Kv in primary and CATH.a neurons (28, 30) . In control CATH.a neurons, ANG II rapidly increases the phosphorylation of CaMKII with a significant increase observed after 5 min of ANG II stimulation ( Fig. 6A ; P Ͻ 0.05 vs. 0 min ANG II). However, ANG II-induced phosphorylation of CaMKII was attenuated in AdMnSOD-infected neurons compared with control, AdEmptyinfected neurons (Fig. 6B) , thus suggesting that mitochondrial O 2 ·Ϫ is involved in the ANG II signaling pathway leading to CaMKII activation. Together with previous reports clearly demonstrating that CaMKII activation is required for the ANG IIinduced inhibition of I Kv and neuronal activation (28, 30, 35) , these data provide evidence for a mechanism by which mitochondria-produced O 2 ·Ϫ mediates these acute ANG II-induced electrophysiological responses.
DISCUSSION
The present study provides direct evidence that ANG II increases mitochondria-produced O 2 ·Ϫ in neurons, which in turn, mediates acute ANG II-dependent intraneuronal signaling. More specifically, we have demonstrated that increased scavenging of mitochondria-produced O 2 ·Ϫ by overexpression of Mn-SOD, the mitochondria-localized isoform of SOD, significantly attenuates ANG II-induced CaMKII activation and inhibition of I Kv in CATH.a neurons. These data provide new insight into the contribution of mitochondria-produced O 2 ·Ϫ in the intraneuronal signaling pathway of ANG II.
Over the past decade, numerous studies have demonstrated that dysregulation of brain angiotensinergic signaling and increased levels of ROS in central neurons are involved in the pathogenesis and sequelae of hypertension and chronic heart failure. In particular, increased sympathoexcitation, which mediates, at least in part, progression of these cardiovascular disorders, has been linked to elevated ROS in the CNS (3, 10, 16, 17, 19, 26, 34) . Many of these previous studies used adenovirus expressing SOD, PEGylated-SOD, and/or SOD mimetics to increase SOD levels in specific ANG II-sensitive, cardiovascular-regulating nuclei in the brain and, in doing so, specifically identified O 2 ·Ϫ as a critical ROS in brain angiotensinergic signaling (3, 12, 16, 17, 26, 34 that Mn-SOD overexpression in the RVLM via adenovirusmediated gene transfer significantly inhibits the pressor response induced by RVLM-administered ANG II. Mn-SOD expression and activity are decreased in the RVLM in SHR compared with normotensive WKY rats, and overexpression of the mitochondria-targeted SOD significantly reduces arterial pressure in SHR (4) . Similarly, in rabbits with pacing-induced heart failure, Mn-SOD expression is significantly reduced in the RVLM (12) . Together, these studies suggest that elevated levels of mitochondria-localized O 2 ·Ϫ contribute to sympathetic neuronal activation in cardiovascular diseases associated with increased ANG II signaling in the brain. Our data presented here provide evidence for an intraneuronal signaling mechanism by which acute ANG II stimulation increases mitochondria-produced O 2 ·Ϫ , which ultimately contributes to neuronal activation.
To directly test the hypothesis that ANG II intraneuronal signaling involves elevated levels of mitochondria-produced O 2 ·Ϫ , we took advantage of the fact that Mn-SOD is the SOD isoform known to exclusively reside in mitochondria. Endogenous Mn-SOD is a nuclear encoded gene, but with a mitochondrial targeting sequence in the NH 2 terminus of the polypeptide, it is efficiently and specifically targeted to mitochondria. In our study, we used adenoviral-mediated gene transfer to increase Mn-SOD protein and activity in CATH.a neuron mitochondria. With such a huge increase in Mn-SOD expression (Fig. 2) , it should be considered that some of the adenoviral-expressed Mn-SOD protein may not enter the mitochondria. Although this is a potential limitation of the present study, previous reports clearly show that Mn-SOD protein is loaded with manganese, to make it active, only as the protein is unfolded and transported into mitochondria (6, 18) . Therefore, endogenous or adenoviral-expressed Mn-SOD in the cytoplasm is inactive. As such, our data showing that adenovirus-mediated overexpression of Mn-SOD virtually abolishes ANG II-dependent neuronal responses and that ANG II directly increases levels of O 2 ·Ϫ in mitochondria indicate that 
mitochondria-produced O 2
·Ϫ is involved in ANG II intraneuronal signaling.
Raizada and Sumners and colleagues clearly identified CaMKII and PKC as signaling proteins that mediate I Kv inhibition and neuronal activation in isolated primary neurons and CATH.a neurons after ANG II stimulation (22, 28, 30, 35) . In the present study, we focused on CaMKII because of recent reports indicating that activation of CaMKII is redox sensitive. In particular, Erickson et al. (8) reported that, in cardiomyocytes, CaMKII is activated by direct ANG II-induced oxidation. In addition, Hongpaisan et al. (13) (5) proposed a feedforward ROSinduced ROS mechanism in RVLM neurons whereby NADPH oxidase-derived ROS damage mitochondrial electron transport chain complexes, which, in turn, results in an increase in mitochondria-produced ROS. Supporting this hypothesis, they report that NADPH oxidase inhibition via p22 phox antisense attenuates an ANG II-induced increase in mitochondria-produced ROS. In addition, restoring electron transport capacity in the RVLM by direct administration of coenzyme Q 10 , a mitochondria electron transporter and antioxidant, significantly attenuated mean arterial pressure and sympathetic tone in rats centrally infused with ANG II (5) . Together, these studies suggest a signaling mechanism and identify a source (i.e., damaged electron transport chain complexes) for the elevated levels of mitochondria-localized O 2 ·Ϫ in ANG II-stimulated neurons, as we report here.
Because the present data were obtained from the catecholaminergic CATH.a neuronal cell line, additional studies using an in vivo model of ANG II-dependent neurogenic hypertension are needed to confirm that, in central neurons, mitochondria-produced O 2 ·Ϫ is involved in the signaling pathway of ANG II. Nevertheless, previous reports (28, 30, 35) clearly demonstrate that the known ANG II intraneuronal signaling mechanisms in primary neurons isolated from the brain are mimicked in CATH.a neurons. In particular, Sumners, Raizada, and colleagues showed that, through an AT 1 receptor-dependent mechanism, ANG II inhibits I Kv similarly in CATH.a neurons and primary neurons isolated from the hypothalamus and brain stem (28, 30, 35) . In addition, they demonstrated that CaMKII inhibition attenuates ANG IIinduced reduction of I Kv in CATH.a and primary neurons (28, 30, 35) . Together, these previous studies convincingly identified CATH.a neurons as a useful neuronal cell model to study ANG II intraneuronal signaling. Nevertheless, as with all cell culturebased studies, future studies should include in vivo experiments designed to explore the role of mitochondria-produced O 2 ·Ϫ in brain angiotensinergic signaling.
In summary, dysregulation of brain ANG II signaling is involved in the pathogenesis of cardiovascular diseases associated with sympathoexcitation, including heart failure and hypertension. To better understand the central actions of ANG II in mediating neuronal activation and sympathoexcitation, it is essential to precisely identify the intraneuronal signaling mechanisms of ANG II. In ANG II-stimulated neurons, NADPH oxidase has been identified as a source of O 2 ·Ϫ , a signaling intermediate involved in controlling membrane ion currents and neuronal activation. Our present study also identifies mitochondria as a critical source of the O 2 ·Ϫ in response to ANG II. In support of this conclusion, overexpression of the mitochondria-targeted O 2 ·Ϫ -scavenging enzyme Mn-SOD attenuates ANG II-induced activation of CaMKII, and inhibition of I Kv in neurons. We propose that new antioxidant-based therapies for cardiovascular diseases associated with ANG II-mediated sympathoexcitation may need to be developed to target mitochondria.
